Literature DB >> 35481647

Relative domain orientation of the L289K HIV-1 reverse transcriptase monomer.

Zhaoyong Xi1, Tatiana V Ilina1, Michel Guerrero1, Lixin Fan2, Nicolas Sluis-Cremer3, Yun-Xing Wang4, Rieko Ishima1.   

Abstract

HIV-1 reverse transcriptase (RT) is a heterodimer comprised p66 and p51 subunits (p66/p51). Several single amino acid substitutions in RT, including L289K, decrease p66/p51 dimer affinity, and reduce enzymatic functioning. Here, small-angle X-ray scattering (SAXS) with proton paramagnetic relaxation enhancement (PRE), 19 F site-specific NMR, and size exclusion chromatography (SEC) were performed for the p66 monomer with the L289K mutation, p66L289K . NMR and SAXS experiments clearly elucidated that the thumb and RNH domains in the monomer do not rigidly interact with each other but are spatially close to the RNH domain. Based on this structural model of the monomer, p66L289K and p51 were predicted to form a heterodimer while p66 and p51L289K not. We tested this hypothesis by SEC analysis of p66 and p51 containing L289K in different combinations and clearly demonstrated that L289K substitution in the p51 subunit, but not in the p66 subunit, reduces p66/p51 formation. Based on the derived monomer model and the importance of the inter-subunit RNH-thumb domain interaction in p66/p51, validated by SEC, the mechanism of p66 homodimer formation was discussed.
© 2022 The Protein Society.

Entities:  

Keywords:  HIV-1; NMR; SAXS; paramagnetic relaxation enhancement; reverse transcriptase; structure

Mesh:

Substances:

Year:  2022        PMID: 35481647      PMCID: PMC8996465          DOI: 10.1002/pro.4307

Source DB:  PubMed          Journal:  Protein Sci        ISSN: 0961-8368            Impact factor:   6.725


  37 in total

1.  Structure-activity relationships of [2',5'-bis-O-(tert-butyldimethylsilyl)-beta-D-ribofuranosyl]- 3'-spiro-5' '-(4' '-amino-1' ',2' '-oxathiole-2' ',2' '-dioxide)thymine derivatives as inhibitors of HIV-1 reverse transcriptase dimerization.

Authors:  Nicolas Sluis-Cremer; Noureddine Hamamouch; Ana San Félix; Sonsoles Velazquez; Jan Balzarini; María-José Camarasa
Journal:  J Med Chem       Date:  2006-08-10       Impact factor: 7.446

2.  Utilization of site-directed spin labeling and high-resolution heteronuclear nuclear magnetic resonance for global fold determination of large proteins with limited nuclear overhauser effect data.

Authors:  J L Battiste; G Wagner
Journal:  Biochemistry       Date:  2000-05-09       Impact factor: 3.162

3.  Human immunodeficiency virus type 1 reverse transcriptase dimer destabilization by 1-[Spiro[4"-amino-2",2" -dioxo-1",2" -oxathiole-5",3'-[2', 5'-bis-O-(tert-butyldimethylsilyl)-beta-D-ribofuranosyl]]]-3-ethylthy mine.

Authors:  N Sluis-Cremer; G I Dmitrienko; J Balzarini; M J Camarasa; M A Parniak
Journal:  Biochemistry       Date:  2000-02-15       Impact factor: 3.162

4.  NMRPipe: a multidimensional spectral processing system based on UNIX pipes.

Authors:  F Delaglio; S Grzesiek; G W Vuister; G Zhu; J Pfeifer; A Bax
Journal:  J Biomol NMR       Date:  1995-11       Impact factor: 2.835

5.  Mutations that abrogate human immunodeficiency virus type 1 reverse transcriptase dimerization affect maturation of the reverse transcriptase heterodimer.

Authors:  Johanna Wapling; Katie L Moore; Secondo Sonza; Johnson Mak; Gilda Tachedjian
Journal:  J Virol       Date:  2005-08       Impact factor: 5.103

6.  The p66 immature precursor of HIV-1 reverse transcriptase.

Authors:  Naima G Sharaf; Eric Poliner; Ryan L Slack; Martin T Christen; In-Ja L Byeon; Michael A Parniak; Angela M Gronenborn; Rieko Ishima
Journal:  Proteins       Date:  2014-05-12

7.  A new generation of peptide-based inhibitors targeting HIV-1 reverse transcriptase conformational flexibility.

Authors:  Audrey Agopian; Edwige Gros; Gudrun Aldrian-Herrada; Nathalie Bosquet; Pascal Clayette; Gilles Divita
Journal:  J Biol Chem       Date:  2008-10-23       Impact factor: 5.157

Review 8.  Novel HIV-1 reverse transcriptase inhibitors.

Authors:  Dirk Jochmans
Journal:  Virus Res       Date:  2008-03-04       Impact factor: 3.303

9.  Asymmetric conformational maturation of HIV-1 reverse transcriptase.

Authors:  Xunhai Zheng; Lalith Perera; Geoffrey A Mueller; Eugene F DeRose; Robert E London
Journal:  Elife       Date:  2015-06-03       Impact factor: 8.140

10.  Novel assay reveals a large, inducible, replication-competent HIV-1 reservoir in resting CD4+ T cells.

Authors:  Anwesha Sanyal; Robbie B Mailliard; Charles R Rinaldo; Deena Ratner; Ming Ding; Yue Chen; Jennifer M Zerbato; Nicholas S Giacobbi; Narasimhan J Venkatachari; Bruce K Patterson; Amanda Chargin; Nicolas Sluis-Cremer; Phalguni Gupta
Journal:  Nat Med       Date:  2017-05-29       Impact factor: 53.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.